Geovax Labs (GOVX)
1.0000 -0.0200 (-1.96%) 10:19 ET [NASDAQ]
1.0000 x 18 1.0100 x 7
Realtime by (Cboe BZX)
1.0000 x 18 1.0100 x 7
Realtime 1.0300 +0.0100 (+0.98%) 09:21 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select FieldsSymbol | GOVX | ABVC | MBRX | ||
Company | Geovax Labs | Abvc Biopharma Inc | Moleculin Biotech CS | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 1.0400 | 1.0100 | 1.0600 | ||
High | 1.0499 | 1.0200 | 1.0750 | ||
Low | 0.9990 | 0.9785 | 1.0000 | ||
Last | 1.0011 | 1.0400 | 1.0200 | ||
Change | -0.0189 | +0.0400 | +0.0334 | ||
% Change | -1.85% | +4.00% | +3.39% | ||
Volume | 88,974 | 21,962 | 367,900 | ||
20-Day Average Volume | 503,054 | 616,533 | 321,420 | ||
Previous Close | 1.0200 | 1.0000 | 0.9866 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | No | No | ||
Technicals | |||||
20-Day Moving Average | 0.9699 | 0.9442 | 0.9063 | ||
20-Day Raw Stochastic | 58.31% | 43.28% | 80.67% | ||
20-Day Relative Strength | 43.36% | 57.79% | 49.69% | ||
Weighted Alpha | -86.49 | -12.87 | -78.82 | ||
Today's Opinion | 88% Sell | 100% Buy | 72% Sell | ||
Previous Opinion | 88% Sell | 88% Buy | 72% Sell | ||
Last Month's Opinion | 100% Sell | 72% Buy | 96% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +23.47% since 04/22/25 | +22.67% since 04/22/25 | -2.02% since 04/22/25 | ||
Low | 0.8300 on 04/23/25 | 0.8060 on 04/23/25 | 0.9760 on 04/28/25 | ||
High | 1.1500 on 04/25/25 | 1.0600 on 04/28/25 | 1.1100 on 04/24/25 | ||
1-Month | |||||
%Chg | -9.02% since 03/28/25 | +18.60% since 03/28/25 | -1.08% since 03/28/25 | ||
Low | 0.7300 on 04/15/25 | 0.7300 on 04/07/25 | 0.6900 on 04/09/25 | ||
High | 1.2100 on 04/02/25 | 1.4000 on 04/01/25 | 1.1100 on 04/24/25 | ||
3-Month | |||||
%Chg | -46.28% since 01/29/25 | +95.78% since 01/29/25 | -33.63% since 01/29/25 | ||
Low | 0.7300 on 04/15/25 | 0.4000 on 02/10/25 | 0.3975 on 02/12/25 | ||
High | 2.0700 on 02/03/25 | 1.4000 on 04/01/25 | 3.6499 on 02/13/25 | ||
6-Month | |||||
%Chg | -49.76% since 10/29/24 | +45.15% since 10/29/24 | -60.73% since 10/29/24 | ||
Low | 0.7300 on 04/15/25 | 0.4000 on 02/10/25 | 0.3975 on 02/12/25 | ||
High | 3.8800 on 11/12/24 | 1.4000 on 04/01/25 | 3.6499 on 02/13/25 | ||
Key Statistics | |||||
Market Capitalization, $K | 14,116 | 15,778 | 13,812 | ||
Shares Outstanding, K | 13,839 | 15,778 | 14,000 | ||
Annual Sales | 3,950,000 | 510,000 | 0 | ||
Annual Net Income | -24,990,000 | -4,900,000 | -21,760,000 | ||
Last Quarter Sales | 860,000 | 390,000 | 0 | ||
Last Quarter Net Income | -8,260,000 | -190,000 | -1,880,000 | ||
60-Month Beta | 3.70 | 0.33 | 2.19 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.30 on 03/27/25 | 0.04 on 04/15/25 | -2.09 on 11/08/24 | ||
Latest Earnings Date | 05/13/25 | 05/16/25 | 05/09/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |